PRKCB

Across TCGA pan-cancer cohorts, PRKCB mass-spec protein differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of PRKCB’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where PRKCB mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types PRKCB is over-expressed in tumor, although a few such as COAD and LUAD show the opposite, repressed pattern.

COAD, HNSC, and CCRCC are the cancer types where PRKCB tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in PRKCB mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	III,IV	−1.348	<.001	11	view →
HNSC	All	All	+0.484	<.001	11	view →
CCRCC	Female	All	+0.604	<.001	10	view →
LUAD	All	II,III,IV	−0.303	<.001	7	view →
LSCC	Male	II,III,IV	−0.432	<.001	6	view →
PDAC	Female	All	+0.987	<.001	5	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

PRKCB–COAD

Open the COAD breakdown →